Concepedia

Shibani Mitra‐Kaushik

SM

Statistics

Publications

14

Citations

518

H-Index

12

Active since

2001

Affiliations

Indian Institute of Science Bangalore(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Bristol-Myers Squibb (United States)

EpiVax (United States)

Sanofi (France)

Shibani Mitra‐Kaushik is an author at Indian Institute of Science Bangalore specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2001–2023

14

Publications

14

T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020

Vibha Jawa, Frances Terry, Jochem Gokemeijer et al. · Frontiers in Immunology · 2020 · 129 citations · Full text

Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma

Shibani Mitra‐Kaushik, John C. S. Harding, Jay L. Hess et al. · Blood · 2004 · 55 citations · Full text

Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants

Shibani Mitra‐Kaushik, John C. S. Harding, Jay L. Hess et al. · Blood · 2004 · 53 citations · Full text

Identification of a Cytotoxic T-Cell Epitope on the Recombinant Nucleocapsid Proteins of Rinderpest and Peste des petits ruminants Viruses Presented as Assembled Nucleocapsids

Shibani Mitra‐Kaushik, R. Nayak, M.S. Shaila · Virology · 2001 · 47 citations

, , +7

Transient Low-Dose Methotrexate Generates B Regulatory Cells That Mediate Antigen-Specific Tolerance to Alglucosidase Alfa

Marguerite Joly, Roderick P. Martin, Shibani Mitra‐Kaushik et al. · The Journal of Immunology · 2014 · 41 citations

, , +27

1–5 of 14